glp-1 news 48 hours The number of Americans taking a drug for weight loss is on the rise., A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago, when The weight-loss-independent hepatoprotective benefits of

Carrier-mediated transport of thyroid hormones into rat glial cells in primary culture

The mind-body connection in chronic pain is well-established, and managing the psychological aspects of your condition supports physical healing

Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition

Second, several states expanded Medicaid coverage to include GLP-1s specifically approved for obesity, such as Wegovy and Zepbound

Large peptides cannot cross intact skin: molecules the size of semaglutide do not passively diffuse through the skin barrier the way small drugs such as nicotine can